Development and validation of mthods for genome and epigenome analysis of clinical samples using lung cancer tissue

Development and validation of mthods for genome and epigenome analysis of clinical samples using lung cancer tissue - Development and validation of mthods for genome and epigenome analysis of clinical samples using lung cancer tissue

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015583

Enrollment

Registered

2014-11-01

Start date

2014-11-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Surgically removed tissue from lung cancer cases

Exclusion criteria

Exclusion criteria: Cases in which concent from patients was not obtained.

Design outcomes

Primary

Measure	Time frame
Production of chromatin immunoprecipitation data, genome variant call and information of chromatin regulation.	—

Secondary

Measure	Time frame
Aseesment results of data quality. Accuracy of nucleotide variant call by ChIPseq data.	—

Countries

Japan

Contacts

Public ContactMasafumi Muratani

Faculty of Medicine, University of Tsukuba Genome Biology

muratani@md.tsukuba.ac.jp029-853-7645

Outcome results